Program-Q  

Bowen test Trial 0507 - UAT (UAT)  

This is Bowen test trial 0507

UAT R13.2 Nan Test Trial_Draft updates  

UAT R13.2 Nan Test Trial

The Efficacy and Safety of Rilzabrutinib in Patients Aged 10 to 65 Years With Sickle-cell Disease (LIBRA)

This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group, group-sequential study (Part A), followed by an open-label LTE period (Part B) to investigate the efficacy, and safety of rilzabrutinib in participants with sickle-cell disease (SCD).Study details include:Study duration: a 52-week double-blind period (Part A), followed by an open-label LTE …

UAT_Local 01-19-May  

This is for UAT_Local 01-19-May.

Dell study 2  

s

Acne study trial  

Acne study trial

testChcekreports  

testChcekreports

TrialXAutomationRun6965  

TrialXAutomationRun6965

TrialXAutomationRun6967  

TrialXAutomationRun6967